The drug is a result of research performed by a collaboration between the University Of Airlangga, the Indonesia Armed Forces (TNI) and the National Intelligence Agency (BIN).
Not the slightest bit of doubt appeared on the face of Airlangga University (Unair) Rector Mohammad Nasih when delivering the news at the Indonesian Army Headquarters (Mabesad) on Saturday (15/8).
It has taken almost half a year for his group to dare to announce their much-awaited finding: the Covid-19 drug.
Nasih explained that the researchers involved were certainly not making conclusions carelessly.
All of the patients involved in the clinical trial were Indonesian Army soldiers who were studying at the Officer Candidate School (Secapa) in Bandung, West Java.
Nasih also expressed appreciation for the Indonesian Army and National Intelligence Agency for providing access to Airlangga University to carry out clinical trials on hundreds of patients in Secapa.
The three drug combinations that Airlangga University clinically tested consisted of lopinavir/ ritonavir and azithromycin, lopinavir/ ritonavir and doxycycline, as well as hydroxychloroquine and azithromycin.
The effectiveness of the Covid-19 drug he said, had reached a 98 percent success rate.
The results of clinical trials conducted show that the Covid-19 drug is ready for use in patients of all levels of severity infected with the SARS-CoV-2 virus.
To begin mass production, Airlangga University, the Indonesian Army and the National Intelligence Agency are awaiting for the production and distribution permit from the Food & Drug Supervisory Agency.
Army Chief of Staff (KSAD) General Andika Perkasa also hopes that the efforts of Unair, the Army and National Intelligence Agency will receive approval so that mass production of the drug can be carried out.
The deputy chairman of the Committee for Covid-19 and National Economic Recovery revealed that State Owned Enterprises (BUMN) Minister Erick Thohir was aware of the existence of the Covid-19 drug that was announced yesterday. “And he supports the production process” he said.
The event was also attended by the leadership of State owned pharmaceutical giant PT Kimia Farma. In addition, pharmaceutical bodies belonging to the Indonesian Army and National Police (Polri) are confirmed to be involved.
Andika said that his team is open to welcome other parties who want to help produce the drug, including private companies.
Positive evidence is the success of the Indonesian Army in curing over one thousand Covid-19 patients in approximately a month. Among the 1,308 Covid patients in the Secapa cluster, 754 patients were declared cured yesterday.
Purwanti, head of the clinical trial team who is also a representative doctor from Airlangga University, said that so far the drug has been effective in curing Covid-19 patients with doses administered twice a day.
Purwanti ensured that the side effects of these drugs are not dangerous for the patient.
Limited Availability Book Now to Avoid Disappointment:
You may also contact our Rentals Manager: Yanthi at +62 815-5890-0389
or our Reception at
PT Bali Luxury Villas at 62-361-284069
No comments:
Post a Comment